Solutions
Company
Resources
Publications
Careers
Contact us
Skip to content
New and Noteworthy
Drug discovery
Topics
Publications
Real-world evidence
Tumor agnostic
Non-small cell lung cancer
Metastatic breast cancer
Breast cancer
Colorectal cancer
Prostate cancer
Treatment patterns
Gastric/Esophageal cancer
Precision medicine
Clinical research
Prospective study
Trial design
Artificial intelligence
Comparative effectiveness
Ovarian cancer
Machine learning
Health equity
Hepatocellular carcinoma
Multiple myeloma
Diffuse large B-Cell lymphoma
Resistance ID
Methodology
Chronic lymphocytic leukemia
Content type
Publication summary
Article
Video
Webinar
Event recap
Case study
Clear
Apply filter
Showing 9 of
0
results
How advances in molecular profiling and linked real-world clinico-omics data are launching a new era of precision oncology
Real-world evidence
Precision medicine
Article
Drug discovery
ASCO 2024 reflections and highlights
Real-world evidence
Clinical research
Event recap
Drug discovery
Prospective study
Breast cancer
Trial design
Artificial intelligence
Effectiveness of PARP inhibitor maintenance therapy in advanced ovarian cancer by BRCA1/2 and HRD signature in real-world practice
ASCO Annual Meeting
Publication summary
Publications
Comparative effectiveness
Drug discovery
Ovarian cancer
Tumor mutational burden measurement from an FDA-approved assay and real-world overall survival on single-agent immune checkpoint inhibitors in over 8,000 patients across 24 cancer types
ASCO Annual Meeting
Publication summary
Publications
Drug discovery
Tumor agnostic
Metastatic patterns and outcomes by HER2 and hormone receptor status in patients with metastatic breast cancer
ASCO Annual Meeting
Publication summary
Publications
Machine learning
Drug discovery
Metastatic breast cancer
Breast cancer
Practice- and provider-level inequities in next-generation sequencing testing by race/ethnicity for patients with advanced non-small cell lung cancer treated in the community setting
ASCO Annual Meeting
Publication summary
Publications
Health equity
Drug discovery
Non-small cell lung cancer
Association between post-treatment alpha-fetoprotein reduction and outcomes in real-world US patients with advanced hepatocellular carcinoma
Cancer
Publication summary
Publications
Drug discovery
Hepatocellular carcinoma
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy
Blood Cancer
Real-world evidence
Publication summary
Publications
Drug discovery
Multiple myeloma
Four ways biotechs can accelerate their pipeline using real-world data in 2021
Real-world evidence
Article
Drug discovery
View more